Both in Biotechnology
MiNK Therapeutics vs ImageneBio
Over the past year INKT returned −17.5% and IMA returned −52.4%; their daily moves had a correlation of 0.09.
INKT −17.5% IMA −52.4%Growth of $1, one year, split-adjusted
| Metric | INKT | IMA |
|---|---|---|
| Price | $11.10 | $4.00 |
| Market cap | $56.6M | $45.4M |
| Today | +0.54% | −2.20% |
| 1 month | −9.0% | −14.9% |
| 6 months | −3.8% | −31.4% |
| Year to date | −0.4% | −42.0% |
| 1 year | −20.9% | −54.1% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $8.8M | $136.2M |
| Dividend yield | — | — |
| Volatility (60d) | 50.9% | 37.4% |
| Short % of float | 2.4% | 0.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).